Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group (Q36616206)
Jump to navigation
Jump to search
scientific article published on February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group |
scientific article published on February 2005 |
Statements
1 reference
Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group (English)
1 reference
F Icli
1 reference
H Akbulut
1 reference
A Uner
1 reference
B Yalcin
1 reference
E Baltali
1 reference
M Altinbas
1 reference
S Coşkun
1 reference
S Komurcu
1 reference
M Erkisi
1 reference
A Demirkazik
1 reference
F C Senler
1 reference
O Sencan
1 reference
A Büyükcelik
1 reference
C Boruban
1 reference
H Onur
1 reference
N Zengin
1 reference
S D Sak
1 reference
1 February 2005
1 reference
1 reference
639-644
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference